Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Johnson and Johnson
Medtronic
Mallinckrodt
Harvard Business School

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

Alza Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ALZA, and when can generic versions of ALZA drugs launch?

ALZA has five approved drugs.

There is one US patent protecting ALZA drugs.

Drugs and US Patents for Alza

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-001 Oct 12, 1993 DISCN No No   Start Trial   Start Trial
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 DISCN No No   Start Trial   Start Trial
Alza EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE brompheniramine maleate; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 019672-001 Mar 29, 1996 DISCN No No   Start Trial   Start Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-002 Oct 12, 1993 DISCN No No   Start Trial   Start Trial
Alza PROGESTASERT progesterone INSERT, EXTENDED RELEASE;INTRAUTERINE 017553-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Alza TESTODERM TTS testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020791-001 Dec 18, 1997 DISCN No No 6,348,210   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alza

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE brompheniramine maleate; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 019672-001 Mar 29, 1996 4,662,880   Start Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-002 Oct 12, 1993 4,704,282   Start Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-001 Oct 12, 1993 4,704,282   Start Trial
Alza TESTODERM TTS testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020791-001 Dec 18, 1997 4,379,454   Start Trial
Alza EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE brompheniramine maleate; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 019672-001 Mar 29, 1996 4,810,502   Start Trial
Alza TESTODERM TTS testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020791-001 Dec 18, 1997 6,348,210   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Mallinckrodt
Merck
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.